Related Experiment Video
Updated: Aug 13, 2026
12:43
Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
Published on: August 16, 2016
[Catecholamines--therapeutic and adverse effects on the heart]
1Departement Geneeskundige Fisiologie en Biochemie, Universiteit van Stellenbosch, Parowvallei, KP.
Summary
Excessive catecholamine release can exhaust the heart's calcium removal capacity, leading to myocyte overload and reduced pump function. This paradox impacts the management of ischemic heart disease.
Area of Science:
- Cardiovascular Physiology
- Cellular Biology
- Biochemistry
Context:
- Catecholamines play a crucial role in cardiac function by modulating intracellular calcium (Ca2+).
- Normal catecholamine activation enhances heart contractility (inotropy) via increased Ca2+ influx.
- This influx is normally balanced by Ca2+ efflux and sarcoplasmic reticulum uptake, protecting myocytes.
Purpose:
- To investigate the consequences of continuous, excessive catecholamine release on cardiac myocyte Ca2+ homeostasis.
- To explore the potential mechanisms leading to Ca2+ overload under sustained high catecholamine conditions.
- To understand the implications of this Ca2+ dysregulation for heart function, particularly in ischemic heart disease.
Summary:
- Catecholamine activation increases cardiac Ca2+ influx, enhancing contractility.
- Sustained, excessive catecholamine release can overwhelm the heart's Ca2+ removal systems (efflux and uptake).
- This overload may stem from Ca2+-dependent depletion of high-energy phosphates, impairing myocyte function and contractility.
Impact:
- Reveals a paradoxical mechanism where excessive catecholamine stimulation can impair cardiac function.
- Highlights the critical role of cellular energy status in maintaining Ca2+ balance during stress.
- Provides insights relevant to the clinical management of conditions involving prolonged catecholamine excess, such as ischemic heart disease.
Related Concept Videos
01:30Adrenergic Agonists: Direct-Acting Agents
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
01:18Adrenergic Agonists: Therapeutic Classification
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...